---
layout: page
title: Publications
author: Johannes C Hellmuth
description: This site list Johannes C. Hellmuth's scientific publications and current preprints.
permalink: /publications/
---

### Publications
[Pubmed](https://www.ncbi.nlm.nih.gov/myncbi/1pUmA1takio5y/bibliography/public/)  
[Google Scholar](https://scholar.google.com/citations?hl=de&user=voIBaRUAAAAJ)  

### Highlights

| <img style="width: 600px" src="/images/graphical-abstract-BCL6-LCR.jpeg"> | [An OCT2 / OCA-B / MEF2B Ternary Complex Controls the Activity and Architecture of an Essential Locus Control Region for Normal and Malignant Germinal Center B-Cells](https://ashpublications.org/blood/article/134/Supplement_1/24/427812/An-OCT2-OCA-B-MEF2B-Ternary-Complex-Controls-the)<br>Hellmuth JC and Chu CS et al. - ASH abstract<br>bioRxiv Preprint will be up shortly<br><br>Our results demonstrate how an intimately linked complex of lineage- and stage-specific factors converges on specific and highly essential enhancer elements to drive the function of a cell-type defining LCR
| <img style="width: 600px" src="/images/graphical-abstract-PIFL.jpeg"> | [Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles](https://www.ncbi.nlm.nih.gov/pubmed/30126979/)<br>Hellmuth JC and Louissaint et al. - ASH abstract<br>Blood. 2018. PubMed PMID: 30126979.<br><br>Duodenal-type follicular lymphoma (DTFL) is a rare and highly indolent follicular lymphoma (FL) variant. Comparative molecular characterization of DTFL to typical FL revealed distinct pathogenic mechanisms. 

### Full list

**Hellmuth JC<sup>*</sup>**, Chu CS<sup>*</sup>, Singh R, Skrabanek LA, Doane A, Elemento O, Roeder RG, Melnick A.  
[An OCT2 / OCA-B / MEF2B Ternary Complex Controls the Activity and Architecture of an Essential Locus Control Region for Normal and Malignant Germinal Center B-Cells.](https://www.ncbi.nlm.nih.gov/pubmed/31723990/)  
Blood. 2019 Nov 13;134(Supplement_1):24. doi: 10.1182/blood-2019-130692. PubMed PMID: 31723990.  

**Hellmuth JC<sup>*</sup>**, Louissaint A Jr<sup>*</sup>, Szczepanowski M, Haebe S, Pastore A, Alig S, Staiger AM, Hartmann S, Kridel R, Ducar MD, Koch P, Dreyling M, Hansmann ML, Ott G, Rosenwald A, Gascoyne RD, Weinstock DM, Hiddemann W, Klapper W, Weigert O.  
[Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles.](https://www.ncbi.nlm.nih.gov/pubmed/30126979/)  
Blood. 2018 Oct 18;132(16):1695-1702. doi: 10.1182/blood-2018-03-837252. PubMed PMID: 30126979.  

Duy C, Teater M, Garrett-Bakelman FE, Lee TC, Meydan C, Glass JL, Li M, **Hellmuth JC**, Mohammad HP, Smitheman KN, Shih AH, Abdel-Wahab O, Tallman MS, Guzman ML, Muench D, Grimes HL, Roboz GJ, Kruger RG, Creasy CL, Paietta EM, Levine RL, Carroll M, Melnick AM.  
[Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML.](https://www.ncbi.nlm.nih.gov/pubmed/31076479/)  
Cancer Discov. 2019 Jul;9(7):872-889. doi: 10.1158/2159-8290.CD-19-0106. PubMed PMID: 31076479. 

Alig S, Jurinovic V, Pastore A, Bararia D, Häbe S, **Hellmuth JC**, Kridel R, Gascoyne R, Schmidt C, Zöllner AK, Buske C, Dreyling M, Unterhalt M, Hiddemann W, Hoster E, Weigert O.  
[Impact of age on genetics and treatment efficacy in follicular lymphoma.](https://www.ncbi.nlm.nih.gov/pubmed/29545350/)  
Haematologica. 2018 Aug;103(8):e364-e367. doi: 10.3324/haematol.2018.187773. PubMed PMID: 29545350.

Eichenauer DA, Plütschow A, Kreissl S, Sökler M, **Hellmuth JC**, Meissner J, Mathas S, Topp MS, Behringer K, Klapper W, Kuhnert G, Dietlein M, Kobe C, Fuchs M, Diehl V, Engert A, Borchmann P.  
[Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.](https://www.ncbi.nlm.nih.gov/pubmed/29133014/)  
Lancet Oncol. 2017 Dec;18(12):1680-1687. doi: 10.1016/S1470-2045(17)30696-4. PubMed PMID: 29133014.  

Zoellner AK, Fritsch S, Prevalsek D, Engel N, Hubmann M, Reibke R, Rieger CT, **Hellmuth JC**, Haas M, Mumm F, Herold T, Ledderose G, Hiddemann W, Dreyling M, Hausmann A, Tischer J.  
[Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma.](https://www.ncbi.nlm.nih.gov/pubmed/25642765/)  
Bone Marrow Transplant. 2015 May;50(5):679-84. doi: 10.1038/bmt.2014.328. PubMed PMID: 25642765.  

Hoffmann FS, Schmidt A, Dittmann Chevillotte M, Wisskirchen C, **Hellmuth J**, Willms S, Gilmore RH, Glas J, Folwaczny M, Müller T, Berg T, Spengler U, Fitzmaurice K, Kelleher D, Reisch N, Rice CM, Endres S, Rothenfusser S.  
[Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virus.](https://www.ncbi.nlm.nih.gov/pubmed/25130193/)  
Hepatology. 2015 Feb;61(2):460-70. doi: 10.1002/hep.27344. PubMed PMID: 25130193. 

Schmidt A, Schwerd T, Hamm W, **Hellmuth JC**, Cui S, Wenzel M, Hoffmann FS, Michallet MC, Besch R, Hopfner KP, Endres S, Rothenfusser S.  
[5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I.](https://www.ncbi.nlm.nih.gov/pubmed/19574455/)  
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12067-72. doi: 10.1073/pnas.0900971106. PubMed PMID: 19574455.

Pippig DA, **Hellmuth JC**, Cui S, Kirchhofer A, Lammens K, Lammens A, Schmidt A, Rothenfusser S, Hopfner KP.  
[The regulatory domain of the RIG-I family ATPase LGP2 senses double-stranded RNA.](https://www.ncbi.nlm.nih.gov/pubmed/19208642/)  
Nucleic Acids Res. 2009 Apr;37(6):2014-25. doi: 10.1093/nar/gkp059. PubMed PMID: 19208642. 

Poeck H, Besch R, Maihoefer C, Renn M, Tormo D, Morskaya SS, Kirschnek S, Gaffal E, Landsberg J, **Hellmuth J**, Schmidt A, Anz D, Bscheider M, Schwerd T, Berking C, Bourquin C, Kalinke U, Kremmer E, Kato H, Akira S, Meyers R, Häcker G, Neuenhahn M, Busch D, Ruland J, Rothenfusser S, Prinz M, Hornung V, Endres S, Tüting T, Hartmann G.  
[5'-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma.](https://www.ncbi.nlm.nih.gov/pubmed/18978796/)  
Nat Med. 2008 Nov;14(11):1256-63. doi: 10.1038/nm.1887. PubMed PMID: 18978796.  
